Reply to: Hippo signalling maintains ER expression and ER+ breast cancer growth
- 3 March 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Nature
- Vol. 591 (7848), E11-E12
- https://doi.org/10.1038/s41586-020-03132-4
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Hippo signalling maintains ER expression and ER+ breast cancer growthNature, 2021
- YAP/TAZ upstream signals and downstream responsesNature, 2018
- The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERαNature, 2017
- Genetic compensation induced by deleterious mutations but not gene knockdownsNature, 2015
- Mesenchymal precursor cells maintain the differentiation and proliferation potentials of breast epithelial cellsBreast Cancer Research, 2014
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCPGenes & Development, 2010